Navigation Links
Spring Creek Healthcare Systems Initiates Strategy to Partner and License DelRX Patents
Date:12/12/2011

NEW YORK, Dec. 12, 2011 /PRNewswire/ -- Spring Creek Healthcare Systems, Inc. (OTC.BB: SCRK.OB), a healthcare solutions company distributing cutting edge solutions for the medical, pharmaceutical and healthcare markets, announced today the launch of its marketing effort to license its DelRX patents.

Spring Creek holds exclusive rights to an innovative drug delivery system that uses a patented process for administering medicine via the mouth, more specifically the inner lining of the cheek, known medically as the buccal mucosa.  This oral spray process compares favorably with the foremost technologies in nasal inhalation and injection, and has the advantage of being nonintrusive and convenient. 

Kelly T. Hickel, Spring Creek CEO commented, "After an IP portfolio review we have elected to launch a marketing effort to license our DelRX patents to prospective clients in the oral diabetes medication space. We have identified a number of companies who could benefit from licensing these patents and are in negotiations with one of those companies."  He continued, "We are excited to launch this effort in order to realize revenues and create shareholder value."

About Spring Creek Healthcare Systems, Inc.

Spring Creek Healthcare Systems, Inc. is a healthcare solutions company distributing cutting edge solutions for the medical, pharmaceutical and healthcare markets to resellers and consumers worldwide. Spring Creek actively pursues emerging opportunities by selecting young companies with innovative concepts and launching these products and services by utilizing a global marketing distribution network to reach target markets. For more information please visit the Company's web site at www.springcreekhcs.com.

Forward-Looking Statements

This press release may contain forward-looking statements within the meaning of Section 27A of the Securities Act of 1933, as amended, and Section 21E of the Securities Exchange Act of 1934, as amended. Investors are cautioned that these forward-looking statements involve uncertainties and risks that could cause actual performance and results of operations to differ materially from those anticipated. These risks and uncertainties include issues related to the ability to: obtain sufficient funding to continue operations, maintain adequate cash flow, profitably exploit new ventures, as well as other factors set forth in Spring Creek's most recently filed Form 10-K and Form 10-Q reports. The forward-looking statements contained herein represent the Company's judgment as of the date of this release and it cautions readers not to place undue reliance on such statements. Spring Creek assumes no obligation to update the statements contained in this release. For further information please visit www.springcreekhcs.com.

Company Contact:
Spring Creek Healthcare Systems, Inc.
Kelly T. Hickel, Chairman and CEO
732-294-8706
kthickel@springcreekhcs.com

 

 

 


'/>"/>
SOURCE Spring Creek Healthcare Systems, Inc.
Copyright©2010 PR Newswire.
All rights reserved

Related medicine technology :

1. Ancor Acquires WellSpring Pharmaceutical Corporation
2. VisionSpring Research Finds Seeing to be the Most Important of Five Senses
3. Cloud-Based Medical Software Company Kareo Attracts $10 Million Investment Led by Greenspring Associates
4. Springhill Medical Center Among First Gulf Coast Hospitals to Receive Medicare Payment for Electronic Health Record Initiative
5. American Scientific Resources Will be a Presenter at the Undiscovered Equities Spring Conference in Boca Raton
6. CardioGenics to Present at the 7th Annual Spring Growth Stock Conference Hosted by Security Research Associates, Inc.
7. Spring Bank Pharmaceuticals Awarded $3.9 Million RO1 NIH Grant to Advance Innovative Hepatitis Program
8. Winner Medical to Attend 65th CMEF Spring11 Exhibition in Shenzhen
9. Keryx Biopharmaceuticals Announces Oral Presentation of Final Zerenex™ Short-Term Phase 3 Data at the Upcoming National Kidney Foundations 2011 Spring Clinical Meetings
10. Cayenne Medical, Inc. Appoints David B. Springer President & CEO
11. U of South Carolina, a Leader in Ultrasound Education, Hosts World Congress in Spring
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:9/9/2017)... 2017  Eli Lilly and Company (NYSE: ... data for lasmiditan, an investigational, oral, first-in-class molecule for ... improvements compared to placebo in the Phase 3 SPARTAN ... 18th Congress of the International Headache Society (IHC) in ... presented today demonstrate lasmiditan,s potential to reduce pain and ...
(Date:9/7/2017)... -- Zimmer Biomet Holdings, Inc. (NYSE and SIX: ZBH), a ... will be participating in the Morgan Stanley 15 th ... hotel in New York.  Zimmer Biomet will present on ... A live webcast of the presentation can ... http://investor.zimmerbiomet.com .   ...
(Date:9/6/2017)... Sept. 6, 2017 NeuroRx, a clinical stage biopharma ... and Behavior (ASIB), has been granted Fast Track status by ... of NRX-100 (ketamine HCl) followed by NRX-101 (D-cycloserine + lurasidone). ... trial of this sequential therapy targeting patients who are admitted ... ...
Breaking Medicine Technology:
(Date:9/24/2017)... ... ... Millions of families and businesses worldwide depend on high quality water from ... water. However, well water can also become contaminated with bacteria and odors from flood ... The EPA does not regulate private drinking water wells. Many states and towns do ...
(Date:9/24/2017)... ... ... boy was walking home and feeling down about himself. He didn’t think he was good ... he can do whatever he wants to do if he puts his mind to it. ... God created him with special talents and gifts. We see his internal dialogue change. He ...
(Date:9/24/2017)... ... ... The Other Sheep”: the ceremonial laws of Moses and the Holy Law of God reexamined. ... author, Maurice Caines. Maurice Caines resides in the sunny isle of Florida, but he ... Adventist Church for many years. He was previously a member of the Anglican Church ...
(Date:9/23/2017)... San Francisco, CA (PRWEB) , ... September 23, 2017 , ... ... Bay Area, is proud to announce a new blog post focused on the ARTAS® ... loss, they understandably hope to turn to the latest, most technologically sophisticated methods of ...
(Date:9/22/2017)... Albert Lea, MN (PRWEB) , ... September 22, 2017 , ... ... and video) at its rally to interview citizens on why they are rallying against ... stories and commitment to this effort against Dr. Noseworthy’s (CEO) decision to close the ...
Breaking Medicine News(10 mins):